Dosing regimens for early alzheimer's disease

TW202635339APending Publication Date: 2026-09-01ELI LILLY & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114137939
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-22
Filing Date
2025-10-01
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074325_001
    Figure TWG2TA001074325_001
  • Figure TWG2TA001074325_002
    Figure TWG2TA001074325_002
  • Figure TWG2TA001074325_003
    Figure TWG2TA001074325_003
Patent Text Reader

Abstract

The invention pertains to a method for reducing amyloid plaques in the brain of a human suffering from a disease characterized by Aβ plaques in the brain, e.g., Alzheimer’s disease. The invention also relates to a method for preventing or reducing amyloid plaques in the brain of a primary prevention subject. Certain aspects of the invention involve methods, doses, or dosing regimens that decrease the risk, frequency, severity, or occurrence of ARIA in subjects.
Need to check novelty before this filing date? Find Prior Art